Comparative evaluation of clinical and radiographic success for Biodentine and MTA in primary molar pulpotomy

TL;DR

This study compares Biodentine and MTA for pulpotomy in primary molars and finds both materials equally effective, with Biodentine being faster to use.

Contribution

The study provides a direct 12-month comparative evaluation of Biodentine and MTA in primary molar pulpotomy.

Findings

Biodentine and MTA showed similar clinical and radiographic success rates (93.3% vs. 91.7%).

Biodentine had significantly shorter procedural time compared to MTA.

Both materials exhibited similarly low rates of internal resorption and furcation radiolucency.

Abstract

Vital pulpotomy is essential for preserving primary molars and while MTA is the gold standard, Biodentine has emerged as a promising
alternative. Therefore, it is of interest to compare Biodentine and MTA in 120 primary molars over a 12-month follow-up. Biodentine showed
a 93.3% success rate versus 91.7% for MTA, with no significant differences in clinical or radiographic outcomes. Procedural time was
significantly shorter with Biodentine and both materials showed similarly low rates of internal resorption and furcation radiolucency.
Thus, biodentine provides comparable success to MTA with added efficiency, supporting its use as a reliable pulpotomy material in primary
molars.